Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
7
NMPA:7
Drug Approvals
Levocetirizine Dihydrochloride 0ral Solution
- Product Name
- 盐酸左西替利嗪口服溶液
- Approval Number
- 国药准字H20254369
- Approval Date
- May 27, 2025
NMPA
Levocetirizine Dihydrochloride Oral Solution
- Product Name
- 盐酸左西替利嗪口服溶液
- Approval Number
- 国药准字H20254368
- Approval Date
- May 27, 2025
NMPA
Lansoprazole for Injection
- Product Name
- 注射用兰索拉唑
- Approval Number
- 国药准字H20223477
- Approval Date
- Jul 7, 2022
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20223104
- Approval Date
- Mar 1, 2022
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20223103
- Approval Date
- Mar 1, 2022
NMPA
Clinical Trials
No trials found
News
No news found